Evaluation of thyroid function in patients receiving Lu-177 DOTATATE treatment

被引：0
|
作者：
Kibar, A. [1 ]
Ince, B.
Nazari, A.
Toplutas, K. N.
Bilgic, S.
Asa, S.
Besli, R. L. Uslu
Sager, M. S.
Sayman, H. B.
Sonmezoglu, K.
机构：
[1] Istanbul Univ, Fac Med, Cerrahpasa, Turkey
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-167
引用
收藏
页码：S470 / S470
页数：1
相关论文
共 50 条
  • [41] ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy
    Love, Charito
    Desai, Neil B.
    Abraham, Tony
    Banks, Kevin P.
    Bodei, Lisa
    Boike, Thomas
    Brown, Richard K. J.
    Bushnell, David L.
    DeBlanche, Lorraine E.
    Dominello, Michael M.
    Francis, Tony
    Grady, Erin C.
    Hobbs, Robert F.
    Hope, Thomas A.
    Kempf, Jeffrey S.
    Pryma, Daniel A.
    Rule, William
    Savir-Baruch, Bital
    Sethi, Ila
    Subramaniam, Rathan M.
    Xiao, Ying
    Schechter, Naomi R.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (06): : 233 - 242
  • [42] ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy
    Love, Charito
    Desai, Neil B.
    Abraham, Tony
    Banks, Kevin P.
    Bodei, Lisa
    Boike, Thomas
    Brown, Richard K. J.
    Bushnell, David L.
    DeBlanche, Lorraine E.
    Dominello, Michael M.
    Francis, Tony
    Grady, Erin C.
    Hobbs, Robert F.
    Hope, Thomas A.
    Kempf, Jeffrey S.
    Pryma, Daniel A.
    Rule, William
    Savir-Baruch, Bital
    Sethi, Ila
    Subramaniam, Rathan M.
    Xiao, Ying
    Schechter, Naomi R.
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (06) : 503 - 511
  • [43] 177LU-DOTATATE IN PATIENTS WITH RECURRENT MENINGIOMA
    Nasrollahi, Elham
    Drappatz, Jan
    NEURO-ONCOLOGY, 2024, 26
  • [44] RELATIONSHIP BETWEEN WHOLE BODY CLEARANCE, KIDNEY DOSE AND GFR IN [LU-177]-DOTATATE THERAPY
    Hennessy, T.
    Bailey, D.
    Willowson, K.
    Chan, D.
    Pavlakis, N.
    Schembri, G.
    Roach, P.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 18 - 19
  • [45] New Model For Lu-177 Dotatate Guide Decisions For Patient Restrictions And Release From Hospital
    Algarni, M.
    Stodilka, R.
    Riffel, J.
    Laidley, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S586 - S587
  • [46] Incorporation Of 177Lu During Care Of 177Lu-PSMA And 177Lu-DOTATATE Therapy Patients
    Happel, C.
    Kranert, W. T.
    Bockisch, B.
    Kratzel, U.
    Baumgarten, J.
    Ngoc, C. Nguyen
    Garayev, E.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S842 - S843
  • [47] Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
    Yeokyeong Shin
    Bo Hyun Moon
    Baek-Yeol Ryoo
    Heung-Moon Chang
    Kyu-pyo Kim
    Yong Sang Hong
    Tae Won Kim
    Jin-Sook Ryu
    Yong-il Kim
    Changhoon Yoo
    Targeted Oncology, 2024, 19 : 41 - 49
  • [48] Preliminary results of 177Lu-DOTATATE radionuclide therapy in patients with medullary thyroid cancer
    Lobo Lopes, F. P. P.
    Vaisman, F.
    de Souza Machado Neto, L.
    de Castro, P. H. R.
    Bulzico, D. A.
    Vilhena, B.
    Carneiro, M.
    Corbo, R.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [49] Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
    Shin, Yeokyeong
    Moon, Bo Hyun
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    Kim, Kyu-pyo
    Hong, Yong Sang
    Kim, Tae Won
    Ryu, Jin-Sook
    Kim, Yong-il
    Yoo, Changhoon
    TARGETED ONCOLOGY, 2024, 19 (01) : 41 - 49
  • [50] Quantitative SPECT imaging with Lu-177: A physical phantom evaluation
    He, Bin
    Nikolopoulou, Anastasia
    Osborne, Joseph
    Vallabhajosula, Shankar
    Goldsmith, Stanley
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
12345